4.6 Article

One-Step Synthesis of Small-Sized and Water-Soluble NaREF4 Upconversion Nanoparticles for In Vitro Cell Imaging and Drug Delivery

期刊

CHEMISTRY-A EUROPEAN JOURNAL
卷 19, 期 8, 页码 2685-2694

出版社

WILEY-V C H VERLAG GMBH
DOI: 10.1002/chem.201203634

关键词

cancer; cell imaging; drug delivery; electron-beam lithography; nanoparticles

资金

  1. National Basic Research Program of China [2010CB327704]
  2. National High Technology Program of China [2011AA03A407]
  3. National Natural Science Foundation of China [NSFC 51272248, 51172228, 51172227, 21101149, 21221061]
  4. Science Technology Development Program of Jilin Province for Youths [20100106]

向作者/读者索取更多资源

Small (228nm) NaREF4 (rare earth (RE)=NdLu, Y) nanoparticles (NPs) were prepared by an oil/water two-phase approach. Meanwhile, hydrophilic NPs can be obtained through a successful phase-transition process by introducing the amphiphilic surfactant sodium dodecylsulfate (SDS) into the same reaction system. Hollow-structured NaREF4 (RE=Y, Yb, Lu) NPs can be fabricated in situ by electron-beam lithography on solid NPs. The MTT assay indicates that these hydrophilic NPs with hollow structures exhibit good biocompatibility. The as-prepared hollow-structured NPs can be used as anti-cancer drug carriers for drug storage/release investigations. Doxorubicin hydrochloride (DOX) was taken as model drug. The release of DOX from hollow -NaLuF4:20%Yb3+, 2%Er3+ exhibits a pH-sensitive release patterns. Confocal microscopy observations indicate that the NPs can be taken up by HeLa cells and show obvious anti-cancer efficacy. Furthermore, -NaLuF4:20%Yb3+, 2%Er3+ NPs show bright-red emission under IR excitation, making both the excitation and emission light fall within the optical window of biological tissues. The application of -NaLuF4:20%Yb3+, 2%Er3+ in the luminescence imaging of cells was also investigated, which shows a bright-red emission without background noise.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据